MILESON GLENNA
Insider CIK 1822241 · ATHA Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATHA Athira Pharma, Inc. | A Award deriv | 2023-01-19 | 2023-01-23 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | P Buy | 2022-12-28 | 2022-12-30 | 50,000 | $2.85 | $142.5K | 159,930 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2022-11-18 | 2022-12-30 | 763 | $2.74 | $2.1K | 109,930 | SEC↗ |
| ATHA Athira Pharma, Inc. | S Sale | 2022-06-23 | 2022-06-24 | 2,614 | $2.69 | $7.0K | 109,167 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2022-06-22 | 2022-06-24 | 10,000 | — | $0 | 111,781 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2022-05-18 | 2022-06-24 | 1,721 | $7.06 | $12.2K | 101,781 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2022-04-11 | 2022-04-12 | 3,000 | — | $0 | 167,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2022-04-11 | 2022-04-12 | 3,000 | $10.64 | $31.9K | 100,060 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2022-01-18 | 2022-01-20 | 170,000 | — | $0 | 170,000 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2022-01-04 | 2022-01-06 | 6,305 | — | $0 | 0 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2022-01-04 | 2022-01-06 | 6,305 | $1.35 | $8.5K | 97,060 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2021-11-18 | 2022-01-06 | 931 | $12.51 | $11.6K | 90,755 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise deriv | 2021-06-10 | 2021-06-10 | 6,305 | — | $0 | 6,305 | SEC↗ |
| ATHA Athira Pharma, Inc. | M Exercise | 2021-06-10 | 2021-06-10 | 6,305 | $1.35 | $8.5K | 89,824 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award | 2021-05-18 | 2021-06-10 | 1,554 | $14.45 | $22.5K | 83,519 | SEC↗ |
| ATHA Athira Pharma, Inc. | A Award deriv | 2021-02-18 | 2021-02-22 | 73,500 | — | $0 | 73,500 | SEC↗ |